Current Computer-Aided Drug Design aims to publish all the latest developments in drug design based on computational techniques. The field of computer-aided drug design has had extensive impact in the area of drug design.
Current Computer-Aided Drug Design is an essential journal for all medicinal chemists who wish to be kept informed and up-to-date with all the latest and important developments in computer-aided methodologies and their applications in drug discovery. Each issue contains a series of timely, in-depth reviews written by leaders in the field, covering a range of computational techniques for drug design, screening, ADME studies, etc., providing excellent rationales for drug development.

“Current Cosmetic Science” publishes original research articles, in-depth reviews/mini reviews, thematic issues, and technical notes covering all aspects of advancements in fundamental and applied research on skin, cosmetic and cosmeceutical products, isolation and comprehensive characterization of natural products and their synthesis to the beneficial effects of the constituents as cosmetic and cosmeceutical ingredients. The journal also explicitly welcomes interdisciplinary contributions considering wider social, cultural, ethical and applied aspects of cosmetic science in modern society.
General subject areas include but not limited to:

• Cosmetic material research and characterization
• Cosmetic and Cosmeceutical formulation development
• Characterization and evaluations
• In vitro and in vivo safety in humans
• Efficacy of cosmetics and cosmeceuticals
• Toxicological studies in various animal models
• Topical products intended for Skin, nails and hair
• Analytical techniques involved in cosmetic and cosmeceutical product formulations and analysis
• Cosmetic Surgery and Dentistry
• Skin physiology and pharmacology
• Aesthetic and rejuvenation research
• Topical and transdermal testing
• Physical chemistry and technology of emulsion and dispersed systems, theory and application of surfactants
• Olfactory research
• Antioxidants
• Natural products

Current Diabetes Reviews publishes full-length/mini-reviews, original research articles, drug clinical trial studies, and guest-edited issues on all the latest advances on diabetes and its related areas dedicated to clinical research, e.g., pharmacology, pathogenesis, complications, epidemiology, clinical care, and therapy. It also includes topics related to diabetic complications such as retinopathy, neuropathy, nephropathy, renal failure and impotence, hypertension, gastrointestinal disorders, hearing impairment, hyperlipidemia, vascular and coronary heart diseases. Articles related to pancreatic islet dysfunction and insulin resistance, adipose tissue function, and glucose homeostasis are also covered. The journal is essential reading for all researchers and clinicians who are involved in the field of diabetes. 

Current Drug Delivery aims to publish peer-reviewed articles, research articles, in-depth reviews/mini-reviews, and drug clinical trials studies in the rapidly developing field of drug delivery. Modern drug research aims to build delivery properties of a drug at the design phase, however in many cases this idea cannot be met and the development of delivery systems becomes as important as the development of the drugs themselves.
The journal aims to cover the latest outstanding developments in drug and vaccine delivery employing physical, physico-chemical and chemical methods. The drugs include a wide range of bioactive compounds from simple pharmaceuticals to peptides, proteins, nucleotides, nucleosides and sugars. The journal will also report progress in the fields of transport routes and mechanisms including efflux proteins and multi-drug resistance.

The journal is essential for all pharmaceutical scientists involved in drug design, development and delivery.

Current Drug Metabolism aims to cover all the latest and outstanding developments in drug metabolism and disposition. The journal serves as an international forum for the publication of timely reviews in drug metabolism. Current Drug Metabolism is an essential journal for academic, clinical, government and pharmaceutical scientists who wish to be kept informed and up-to-date with the latest and most important developments. The journal covers the following areas:



In vitro systems including CYP-450; enzyme induction and inhibition; drug-drug interactions and enzyme kinetics; pharmacokinetics, toxicokinetics, species scaling and extrapolations; P-glycoprotein and transport carriers; target organ toxicity and interindividual variability; drug metabolism and disposition studies; extrahepatic metabolism; phase I and phase II metabolism; recent developments for the identification of drug metabolites and adducts.

Current Drug Safety publishes frontier reviews on all the latest advances on drug safety. The journal's aim is to publish the highest quality review articles in the field. Topics covered include: adverse effects of individual drugs and drug classes, management of adverse effects, pharmacovigilance and pharmacoepidemiology of new and existing drugs, post-marketing surveillance. The journal is essential reading for all researchers and clinicians involved in drug safety.

CNS & Neurological Disorders - Drug Targets aims to cover all the latest and outstanding developments on the medicinal chemistry, pharmacology, molecular biology, genomics and biochemistry of contemporary molecular targets involved in neurological and central nervous system (CNS) disorders e.g. disease specific proteins, receptors, enzymes, genes. Each issue of the journal will contain a series of timely in-depth reviews written by leaders in the field covering a range of current topics on drug targets involved in neurological and CNS disorders. As the discovery, identification, characterization and validation of novel human drug targets for neurological and CNS drug discovery continues to grow; this journal will be essential reading for all pharmaceutical scientists involved in drug discovery and development.